ATE226058T1 - Verwendung von lysin zur behandlung des haarausfalls - Google Patents

Verwendung von lysin zur behandlung des haarausfalls

Info

Publication number
ATE226058T1
ATE226058T1 AT97925169T AT97925169T ATE226058T1 AT E226058 T1 ATE226058 T1 AT E226058T1 AT 97925169 T AT97925169 T AT 97925169T AT 97925169 T AT97925169 T AT 97925169T AT E226058 T1 ATE226058 T1 AT E226058T1
Authority
AT
Austria
Prior art keywords
pct
lysine
hair loss
treat hair
sec
Prior art date
Application number
AT97925169T
Other languages
English (en)
Inventor
David Hugh Rushton
Road Harefield
Original Assignee
Bio Scient Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Scient Ltd filed Critical Bio Scient Ltd
Application granted granted Critical
Publication of ATE226058T1 publication Critical patent/ATE226058T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT97925169T 1996-06-10 1997-06-06 Verwendung von lysin zur behandlung des haarausfalls ATE226058T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9612108A GB2314019B (en) 1996-06-10 1996-06-10 The use of L-Lysine in the treatment of hair loss
PCT/GB1997/001542 WO1997047276A1 (en) 1996-06-10 1997-06-06 The use of l-lysine in the treatment of hair loss

Publications (1)

Publication Number Publication Date
ATE226058T1 true ATE226058T1 (de) 2002-11-15

Family

ID=10795046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925169T ATE226058T1 (de) 1996-06-10 1997-06-06 Verwendung von lysin zur behandlung des haarausfalls

Country Status (13)

Country Link
US (1) US6136860A (de)
EP (1) EP0914078B1 (de)
JP (1) JP2000511876A (de)
AT (1) ATE226058T1 (de)
AU (1) AU721751B2 (de)
CA (1) CA2257607C (de)
DE (1) DE69716434T2 (de)
DK (1) DK0914078T3 (de)
ES (1) ES2185942T3 (de)
GB (1) GB2314019B (de)
NZ (1) NZ333108A (de)
PT (1) PT914078E (de)
WO (1) WO1997047276A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1773600A (en) * 1998-12-21 2000-07-12 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
ITMI20011732A1 (it) * 2001-08-07 2003-02-07 Indena Spa Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto
BRPI0418784B1 (pt) 2004-04-28 2014-08-19 Cosmo Oil Co Ltd Composição restauradora de cabelo, e, método não-terapêutico para restaurar cabelo
US7705010B2 (en) * 2005-02-22 2010-04-27 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
CN101460138B (zh) * 2006-06-08 2011-07-20 味之素株式会社 生发组合物
DE102008012988A1 (de) * 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
NZ732075A (en) 2014-10-29 2022-09-30 Samson Clinical Pty Ltd Detection and treatment of excessive hair shedding
EP3175837A1 (de) 2015-12-01 2017-06-07 Noxell Corporation Verfahren zur haarbehandlung
ES2725009T3 (es) * 2016-03-04 2019-09-18 Laboratorio Reig Jofre S A Comprimidos con un alto contenido de principios activos útiles para el tratamiento de la pérdida de cabello o la estimulación de su crecimiento
KR20240064747A (ko) * 2017-07-12 2024-05-13 삼손 클리니컬 피티와이 엘티디 모발 성장을 촉진시키고, 탈모 또는 과도한 머리카락 빠짐의 치료

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB720561A (en) * 1952-04-17 1954-12-22 Frederick Victor Wells Improvements in preparations for application to the hair and scalp
LU54223A1 (de) * 1967-08-01 1969-03-24
BE789856A (fr) * 1971-10-13 1973-02-01 Tixier Georges Medicament a base de derives de la lysine susceptibles de stimuler differents metabolismes, en particulier la genese des leucocytes
DE3118882C2 (de) * 1981-05-13 1985-11-14 Rudolf V. Dr.rer.nat Dipl.-Chem. 5024 Pulheim Noronha Mittel gegen Haarausfall und zur Förderung des Haarwuchs
JPS60142908A (ja) * 1983-12-29 1985-07-29 Kanebo Ltd 養毛化粧料
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
WO1987000427A1 (en) * 1985-07-18 1987-01-29 Proctor Peter H Topical composition and method for stimulating hair growth
DE68917946T2 (de) * 1988-01-29 1995-01-05 Peter H Proctor Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5133958A (en) * 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
US5122369A (en) * 1990-03-30 1992-06-16 Harmony Health Products, Inc. Nutrient composition for preventing hair loss
FR2669224B1 (fr) * 1990-11-15 1995-04-28 Marcel Contier Compositions capillaires, destinees notamment a la neutralisation de l'acide lactique du cuir chevelu et methode de traitement cosmetique du cuir chevelu.
GB9210768D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
DE19520662A1 (de) * 1995-06-07 1996-12-12 Beiersdorf Ag Mittel zur Behandlung von Kopfschuppen und zur Behandlung der Haare

Also Published As

Publication number Publication date
US6136860A (en) 2000-10-24
GB2314019A8 (en) 1998-03-30
WO1997047276A1 (en) 1997-12-18
DE69716434D1 (de) 2002-11-21
DE69716434T2 (de) 2003-06-18
HK1019552A1 (en) 2000-02-18
ES2185942T3 (es) 2003-05-01
JP2000511876A (ja) 2000-09-12
GB9612108D0 (en) 1996-08-14
NZ333108A (en) 2000-05-26
GB2314019B (en) 2000-03-15
AU721751B2 (en) 2000-07-13
AU3040497A (en) 1998-01-07
CA2257607C (en) 2010-11-02
GB2314019A (en) 1997-12-17
CA2257607A1 (en) 1997-12-18
PT914078E (pt) 2003-02-28
DK0914078T3 (da) 2003-02-17
EP0914078B1 (de) 2002-10-16
EP0914078A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69716434D1 (de) Verwendung von lysin zur behandlung des haarausfalls
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
DE69827001D1 (de) Gewebedezellularization
DE69317578D1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
ATE216245T1 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
NO961809D0 (no) Ny drikk
ATE49115T1 (de) Haarbehandlungsmittel.
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
DE69701346D1 (de) Verwendung von siliciumhaltigen Verbindungen zum Färben von Menschlichen Keratinfasern; neue Verbindungen und Zusammensetzungen, die diese enthalten.
ATE104551T1 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
ATE151980T1 (de) Zusammensetzung zur haarpflege
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE227969T1 (de) Verfahren und mittel zur dauerhaften verformung von keratinfasern
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE143804T1 (de) Zusammensetzung zur behandlung von mastitis und metritis
ATE212845T1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0914078

Country of ref document: EP

REN Ceased due to non-payment of the annual fee